financetom
Business
financetom
/
Business
/
Salesforce's Agentforce Could Drive Near-Term Data Cloud Growth, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce's Agentforce Could Drive Near-Term Data Cloud Growth, RBC Says
Sep 25, 2024 10:44 PM

10:56 AM EDT, 09/19/2024 (MT Newswires) -- Salesforce's ( CRM ) new Agentforce product could drive the growth of its Data Cloud platform in the near term as customers look to "get their data estate in order" before assessing generative artificial intelligence, RBC Capital Markets said.

Agentforce will allow its users to build AI agents in their Salesforce Clouds, using their existing data, and automate basic tasks. The new product will have a credit/usage-based pricing model and RBC said in a Wednesday note that it can be monetized as a "platform for companies to be built on top of."

"While management noted the willingness to adopt Agentforce is the highest among AI products to date, we expect adoption to be measured," RBC added, noting that Salesforce's ( CRM ) AI strategy continues to be "underwhelming."

Agentforce is set to be generally available in October.

RBC has a outperform rating on Salesforce ( CRM ), with a $300 price target.

Price: 259.57, Change: +7.13, Percent Change: +2.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MFA Financial Prices $75 Million Offering of Senior Notes Due 2029
MFA Financial Prices $75 Million Offering of Senior Notes Due 2029
Apr 15, 2024
05:05 PM EDT, 04/15/2024 (MT Newswires) -- MFA Financial ( MFA/PB ) said late Monday it priced an underwritten public offering of $75 million of 9.0% senior notes due 2029. Underwriters, including Morgan Stanley and RBC Capital Markets, have the option to purchase up to an additional $11.25 million of notes, the company added. It expects to close the offering...
ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer
ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer
Apr 15, 2024
05:00 PM EDT, 04/15/2024 (MT Newswires) -- ORIC Pharmaceuticals ( ORIC ) said late Monday it dosed the first patients in three dose expansion groups in a phase 1b trial of ORIC-114 in people with lung cancer. The phase 1b expansion part of the study will assess the safety and efficacy of the candidate drug at the provisional recommended phase...
Jpmorgan Chase & Insider Sold Shares Worth $32,824,625, According to a Recent SEC Filing
Jpmorgan Chase & Insider Sold Shares Worth $32,824,625, According to a Recent SEC Filing
Apr 15, 2024
05:01 PM EDT, 04/15/2024 (MT Newswires) -- James Dimon, Director, Chairman & CEO, on April 15, 2024, sold 178,222 shares in Jpmorgan Chase ( JPM ) & (JPM) for $32,824,625. Following the Form 4 filing with the SEC, Dimon has control over a total of 7,662,091 shares of the company, with 264,461 shares held directly and 7,397,630 controlled indirectly. SEC...
Semrush Holdings Insider Sold Shares Worth $1,148,228, According to a Recent SEC Filing
Semrush Holdings Insider Sold Shares Worth $1,148,228, According to a Recent SEC Filing
Apr 15, 2024
05:00 PM EDT, 04/15/2024 (MT Newswires) -- Brian Mulroy, Chief Financial Officer, on April 11, 2024, sold 89,079 shares in Semrush Holdings ( SEMR ) for $1,148,228. Following the Form 4 filing with the SEC, Mulroy has control over a total of 441,625 shares of the company, with 441,625 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1831840/000183184024000017/xslF345X03/wk-form4_1713214696.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved